"10.1371_journal.pone.0031558","plos one","2012-02-21T00:00:00Z","Jessica H Brehm; Yanille Scott; Dianna L Koontz; Steven Perry; Scott Hammer; David Katzenstein; John W Mellors; Nicolas Sluis-Cremer; for the AIDS Clinical Trials Group Study 175 Protocol Team","Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America; Department of Infectious Disease and Microbiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, United States of America; Columbia University Medical Center, New York, New York, United States of America; Division of Infectious Diseases, Center for AIDS Research, Stanford, California, United States of America","Conceived and designed the experiments: JM NSC JB YS. Performed the experiments: JB YS DK SP. Analyzed the data: JB YS JM NSC. Contributed reagents/materials/analysis tools: DK SH. Wrote the paper: JM NSC.","John Mellors is a consultant to Gilead Sciences, Merck and RFS Pharmaceuticals and owns share options in RFS Pharmaceuticals. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2012","02","Jessica H Brehm","JHB",9,TRUE,4,4,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
